Shares of Dynatronics Co. (NASDAQ:DYNT) have earned an average rating of “Buy” from the six research firms that are covering the company, MarketBeat reports. Two investment analysts have rated the stock with a hold recommendation and three have given a buy recommendation to the company. The average 1 year price target among analysts that have issued ratings on the stock in the last year is $3.88.

Several brokerages have recently issued reports on DYNT. Zacks Investment Research upgraded Dynatronics from a “sell” rating to a “hold” rating in a research report on Tuesday, April 16th. Roth Capital reduced their price objective on Dynatronics from $4.50 to $4.00 and set a “buy” rating for the company in a research note on Wednesday, February 13th. ValuEngine lowered Dynatronics from a “buy” rating to a “hold” rating in a research note on Wednesday, May 1st. Aegis assumed coverage on Dynatronics in a research note on Wednesday, June 5th. They set a “buy” rating for the company. Finally, Maxim Group assumed coverage on Dynatronics in a research note on Thursday, April 4th. They set a “buy” rating and a $3.75 price objective for the company.

Shares of DYNT stock traded up $0.03 during mid-day trading on Wednesday, hitting $1.44. 1,811 shares of the stock traded hands, compared to its average volume of 9,068. Dynatronics has a twelve month low of $1.21 and a twelve month high of $3.60. The stock has a market cap of $12.12 million, a PE ratio of -3.60 and a beta of -0.03. The company has a debt-to-equity ratio of 0.34, a quick ratio of 0.60 and a current ratio of 1.43.

Dynatronics (NASDAQ:DYNT) last issued its quarterly earnings results on Tuesday, May 14th. The medical equipment provider reported ($0.09) earnings per share (EPS) for the quarter, meeting the consensus estimate of ($0.09). Dynatronics had a negative return on equity of 12.65% and a negative net margin of 1.92%. The company had revenue of $14.55 million for the quarter, compared to analysts’ expectations of $14.64 million. Equities research analysts predict that Dynatronics will post -0.23 earnings per share for the current year.

An institutional investor recently bought a new position in Dynatronics stock. Vanguard Group Inc acquired a new position in shares of Dynatronics Co. (NASDAQ:DYNT) in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The firm acquired 27,747 shares of the medical equipment provider’s stock, valued at approximately $79,000. Vanguard Group Inc owned approximately 0.34% of Dynatronics as of its most recent SEC filing. Institutional investors and hedge funds own 13.02% of the company’s stock.

Dynatronics Company Profile

Dynatronics Corporation designs, manufactures, markets, and distributes orthopedic soft goods, medical supplies, and physical therapy and rehabilitation equipment in the United States and internationally. It offers ankle and wrist braces, hot packs, cold packs, lumbar rolls, cervical collars, slings, cervical pillows, bolsters, positioning wedges, back cushions, lotions and gels, paper products, athletic tape, splints, elastic wraps, exercise weights, exercise bands and tubing, electrodes, and rehabilitation and back products.

Featured Story: What is a put option?

Receive News & Ratings for Dynatronics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dynatronics and related companies with MarketBeat.com's FREE daily email newsletter.